

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb268</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Current State of Cartilage Tissue Engineering  using Nanofibrous Scaffolds and Stem Cells</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Kazemnejad</surname><given-names>Somaieh</given-names></name></contrib><aff>Nanobiotechnology Research Center, Avicenna Research Institute      , Tehran, Iran</aff><aff>Immunology Research Center, Faculty of Medicine, Iran University of Medical Sciences      , Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Khanmohammadi</surname><given-names>Manijeh</given-names></name></contrib><aff>Department of Medical Physics, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Baheiraei</surname><given-names>Nafiseh</given-names></name></contrib><aff>Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Arasteh</surname><given-names>Shaghayegh</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>9</volume>
      <issue>2</issue>
      <fpage>50</fpage>
      <lpage>65</lpage>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Cartilage is an avascular, aneural, and alymphatic connective tissue with a limited capacity caused by low mitotic activity of its resident cells, chondrocytes. Natural repair of full thickness cartilage defects usually leads to the formation of fibrocartilage with lower function and mechanical force compared with the original hyaline cartilage and further deterioration can occur. Tissue engineering and regenerative medicine is a promising strategy to repair bone and articular cartilage defects and rehabilitate joint functions by focusing on the optimal combination of cells, material scaffolds, and signaling molecules. The unique physical and topographical properties of nanoﬁbrous structures allow them to mimic the extracellular matrix of native cartilage, making an appropriate resemblance to induce cartilage tissue regeneration and reconstruction. To improve simulation of native cartilage, the incorporation of nanofibrous scaffolds with suitable corresponsive cells could be effective. In this review article, an attempt was made to present the current state of cartilage tissue engineering using nanofibrous scaffolds and stem cells as high proliferative immune privilege cells with chondrogenic differentiation ability. The comprehensive information was retrieved by search of relevant subject headings in Medline/Pubmed and Elsevier databases.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
